Literature DB >> 26823226

Xpert MTB/RIF for tuberculosis testing: access and price in highly privatised health markets.

Lekha Puri1, Collins Oghor1, Claudia M Denkinger2, Madhukar Pai3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26823226     DOI： 10.1016/S2214-109X(15)00269-7

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN： 2214-109X            Impact factor:   26.763


× No keyword cloud information.
  13 in total

1.  Direct Detection of Rifampin and Isoniazid Resistance in Sputum Samples from Tuberculosis Patients by High-Resolution Melt Curve Analysis.

Authors:  Divya Anthwal; Rakesh Kumar Gupta; Manpreet Bhalla; Shinjini Bhatnagar; Jaya Sivaswami Tyagi; Sagarika Haldar
Journal:  J Clin Microbiol       Date:  2017-03-22       Impact factor: 5.948

Review 2.  Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?

Authors:  Heidi Albert; Ruvandhi R Nathavitharana; Chris Isaacs; Madhukar Pai; Claudia M Denkinger; Catharina C Boehme
Journal:  Eur Respir J       Date:  2016-07-13       Impact factor: 16.671

3.  Private Practitioners' Perspectives on Their Involvement With the Tuberculosis Control Programme in a Southern Indian State.

Authors:  Solomon Salve; Kabir Sheikh; John Dh Porter
Journal:  Int J Health Policy Manag       Date:  2016-11-01

4.  HMGB1 level in cerebrospinal fluid as a complimentary biomarker for the diagnosis of tuberculous meningitis.

Authors:  Yan Chen; Jun Zhang; Xiaofei Wang; Yu Wu; Li Zhu; Longkun Lu; Qian Shen; Yanghua Qin
Journal:  Springerplus       Date:  2016-10-12

5.  Tuberculosis innovations mean little if they cannot save lives.

Authors:  Madhukar Pai; Jennifer Furin
Journal:  Elife       Date:  2017-05-02       Impact factor: 8.140

6.  An evaluation of automated chest radiography reading software for tuberculosis screening among public- and private-sector patients.

Authors:  Md Toufiq Rahman; Andrew J Codlin; Md Mahfuzur Rahman; Ayenun Nahar; Mehdi Reja; Tariqul Islam; Zhi Zhen Qin; Md Abdus Shakur Khan; Sayera Banu; Jacob Creswell
Journal:  Eur Respir J       Date:  2017-05-21       Impact factor: 16.671

7.  New TB Tools Need to be Affordable in the Private Sector: The Case Study of Xpert MTB/RIF.

Authors:  Nirros Ponnudurai; Claudia M Denkinger; Wayne Van Gemert; Madhukar Pai
Journal:  J Epidemiol Glob Health       Date:  2018-12

8.  Realizing the "40 by 2022" Commitment from the United Nations High-Level Meeting on the Fight to End Tuberculosis: What Will It Take to Meet Rapid Diagnostic Testing Needs?

Authors:  Amy S Piatek; William A Wells; Kaiser C Shen; Charlotte E Colvin
Journal:  Glob Health Sci Pract       Date:  2019-12-23

9.  Low-cost detection of norovirus using paper-based cell-free systems and synbody-based viral enrichment.

Authors:  Duo Ma; Luhui Shen; Kaiyue Wu; Chris W Diehnelt; Alexander A Green
Journal:  Synth Biol (Oxf)       Date:  2018-09-19

Review 10.  "Nomen Omen": Exploring Connected Healthcare through the Perspective of Name Omen.

Authors:  Sonia Chien-I Chen; Chenglian Liu; Ridong Hu; Yiyi Mo; Xiupin Ye
Journal:  Healthcare (Basel)       Date:  2020-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.